Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: <i>post hoc</i> analyses of three randomized double‐blind studies
Jessica Ailani(Georgetown University), Sheena K. Aurora(Impel Neuropharma (United States)), Q. Zhang(Eli Lilly (United States)), Kory Schuh(Eli Lilly (United States)), Eric Pearlman(University of California, San Francisco), Arnold Nagy(Carolina Headache Institute)
Cited by 26
Related Papers
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
CGRP and the Trigeminal System in Migraine
|Headache The Journal of Head and Face Pain|2019|483
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
|Nature Communications|2016|446